Excelsior Medical Co Ltd (4104) - Total Assets

Latest as of September 2025: NT$18.80 Billion TWD ≈ $592.39 Million USD

Based on the latest financial reports, Excelsior Medical Co Ltd (4104) holds total assets worth NT$18.80 Billion TWD (≈ $592.39 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Excelsior Medical Co Ltd - Total Assets Trend (2002–2024)

This chart illustrates how Excelsior Medical Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see market value of Excelsior Medical Co Ltd for the company's overall valuation and market capitalisation.

Excelsior Medical Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Excelsior Medical Co Ltd's total assets of NT$18.80 Billion consist of 60.0% current assets and 40.0% non-current assets. Review Excelsior Medical Co Ltd (4104) total liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (TWD)	% of Total Assets
Cash & Equivalents	NT$0.00	20.6%
Accounts Receivable	NT$5.61 Billion	27.5%
Inventory	NT$1.39 Billion	6.8%
Property, Plant & Equipment	NT$0.00	0.0%
Intangible Assets	NT$18.18 Million	0.1%
Goodwill	NT$28.95 Million	0.1%

Asset Composition Trend (2002–2024)

This chart illustrates how Excelsior Medical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 4104 share price today for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Excelsior Medical Co Ltd's current assets represent 60.0% of total assets in 2024, an increase from 0.0% in 2002.
Cash Position: Cash and equivalents constituted 20.6% of total assets in 2024, up from 5.5% in 2002.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2002.
Asset Diversification: The largest asset category is accounts receivable at 27.5% of total assets.

Excelsior Medical Co Ltd Competitors by Total Assets

Key competitors of Excelsior Medical Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Mayne Pharma Group Ltd AU:MYX	Australia	AU$1.01 Billion
Ebos Group Ltd AU:EBO	Australia	AU$8.80 Billion
Techno Medical Public Company Limited BK:TM	Thailand	฿916.99 Million
Shenzhen Glory Medical Co Ltd SHE:002551	China	CN¥3.22 Billion
Cencora Inc. NYSE:COR	USA	$81.65 Billion
COSMOS HEALTH NEW DL-01 F:V67A	Germany	€65.48 Million
Euromedis Groupe SA PA:ALEMG	France	€39.49 Million
111 Inc NASDAQ:YI	USA	$280.49 Million

Excelsior Medical Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.63	1.34	2.11
Quick Ratio	1.41	1.21	1.90
Cash Ratio	0.00	0.00	0.00
Working Capital	NT$4.02 Billion	NT$3.49 Billion	NT$4.48 Billion

Excelsior Medical Co Ltd - Advanced Valuation Insights

This section examines the relationship between Excelsior Medical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.65
Latest Market Cap to Assets Ratio	0.02
Asset Growth Rate (YoY)	12.7%
Total Assets	NT$20.37 Billion
Market Capitalization	$428.48 Million USD

Valuation Analysis

Below Book Valuation: The market values Excelsior Medical Co Ltd's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Excelsior Medical Co Ltd's assets grew by 12.7% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Excelsior Medical Co Ltd (2002–2024)

The table below shows the annual total assets of Excelsior Medical Co Ltd from 2002 to 2024.

Year	Total Assets	Change
2024-12-31	NT$20.37 Billion ≈ $641.70 Million	+12.66%
2023-12-31	NT$18.08 Billion ≈ $569.62 Million	+9.69%
2022-12-31	NT$16.48 Billion ≈ $519.29 Million	+9.12%
2021-12-31	NT$15.11 Billion ≈ $475.89 Million	+7.86%
2020-12-31	NT$14.00 Billion ≈ $441.22 Million	+1.74%
2019-12-31	NT$13.76 Billion ≈ $433.67 Million	-1.54%
2018-12-31	NT$13.98 Billion ≈ $440.47 Million	-6.49%
2017-12-31	NT$14.95 Billion ≈ $471.05 Million	-11.14%
2016-12-31	NT$16.83 Billion ≈ $530.11 Million	+7.75%
2015-12-31	NT$15.62 Billion ≈ $491.96 Million	+4.92%
2014-12-31	NT$14.88 Billion ≈ $468.89 Million	+4.87%
2013-12-31	NT$14.19 Billion ≈ $447.12 Million	+8.42%
2012-12-31	NT$13.09 Billion ≈ $412.38 Million	+4.62%
2011-12-31	NT$12.51 Billion ≈ $394.16 Million	+7.03%
2010-12-31	NT$11.69 Billion ≈ $368.27 Million	+27.96%
2009-12-31	NT$9.14 Billion ≈ $287.81 Million	+91.40%
2008-12-31	NT$4.77 Billion ≈ $150.37 Million	+1.56%
2007-12-31	NT$4.70 Billion ≈ $148.07 Million	+18.75%
2006-12-31	NT$3.96 Billion ≈ $124.69 Million	-0.84%
2005-12-31	NT$3.99 Billion ≈ $125.75 Million	+4.19%
2004-12-31	NT$3.83 Billion ≈ $120.69 Million	+34.13%
2003-12-31	NT$2.86 Billion ≈ $89.98 Million	+39.75%
2002-12-31	NT$2.04 Billion ≈ $64.39 Million	--

About Excelsior Medical Co Ltd

TW:4104 Taiwan Medical Distribution

Market Cap

$428.48 Million

NT$13.60 Billion TWD

Market Cap Rank

#13150 Global

#502 in Taiwan

Share Price

NT$72.20

Change (1 day)

+0.42%

52-Week Range

NT$68.10 - NT$86.00

All Time High

NT$100.50